Medical Care

Global Antibody Development Services Market Research Report 2025

The global market for Antibody Development Services was valued at US$ 1527 million in the year 2024 and is projected to reach a revised size of US$ 2664 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Antibody development services refer to specialized services provided by contract research organizations (CROs) or biotechnology companies to support the discovery, engineering, and production of antibodies for various research, diagnostic, therapeutic, and biotechnological applications. These services encompass a wide range of activities aimed at generating specific antibodies against target antigens, optimizing their properties, and producing them in suitable quantities. Antibodies are crucial tools in the fields of immunology, molecular biology, drug development, and diagnostics.
Single-cell RNA sequencing and antibody profiling techniques were increasingly being used to isolate and characterize individual B cells, allowing for the identification of rare and potent antibodies with therapeutic potential.
This report aims to provide a comprehensive presentation of the global market for Antibody Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Development Services.
The Antibody Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
R&D Systems
Leinco Technologies
Rockland Immunochemicals, Inc. (Rockland)
Bio-Rad
BioGenes
ProteoGenix
Labcorp
Inotiv, Inc.
ProMab Biotechnologies
Kemp Proteins
Synaptic Systems
ARVYS Proteins, Inc.
BBI Solutions
Innovagen AB
BIOTEM
Medimab
OriGene
Abeomics Inc.
RayBiotech
Genscript Biotech Corporation
Sino Biological
Abzena Ltd
Creative Biolabs
Abcam
Antibodies Incorporated
Segment by Type
Monoclonal Antibody Development
Polyclonal Antibody Development
Segment by Application
Medical Industry
Biological Industry
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody Development
1.2.3 Polyclonal Antibody Development
1.3 Market by Application
1.3.1 Global Antibody Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Industry
1.3.3 Biological Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Development Services Market Perspective (2020-2031)
2.2 Global Antibody Development Services Growth Trends by Region
2.2.1 Global Antibody Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Development Services Historic Market Size by Region (2020-2025)
2.2.3 Antibody Development Services Forecasted Market Size by Region (2026-2031)
2.3 Antibody Development Services Market Dynamics
2.3.1 Antibody Development Services Industry Trends
2.3.2 Antibody Development Services Market Drivers
2.3.3 Antibody Development Services Market Challenges
2.3.4 Antibody Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Development Services Players by Revenue
3.1.1 Global Top Antibody Development Services Players by Revenue (2020-2025)
3.1.2 Global Antibody Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Antibody Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Development Services Revenue
3.4 Global Antibody Development Services Market Concentration Ratio
3.4.1 Global Antibody Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Development Services Revenue in 2024
3.5 Global Key Players of Antibody Development Services Head office and Area Served
3.6 Global Key Players of Antibody Development Services, Product and Application
3.7 Global Key Players of Antibody Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Development Services Breakdown Data by Type
4.1 Global Antibody Development Services Historic Market Size by Type (2020-2025)
4.2 Global Antibody Development Services Forecasted Market Size by Type (2026-2031)
5 Antibody Development Services Breakdown Data by Application
5.1 Global Antibody Development Services Historic Market Size by Application (2020-2025)
5.2 Global Antibody Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Development Services Market Size (2020-2031)
6.2 North America Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Development Services Market Size by Country (2020-2025)
6.4 North America Antibody Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Development Services Market Size (2020-2031)
7.2 Europe Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Development Services Market Size by Country (2020-2025)
7.4 Europe Antibody Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Development Services Market Size (2020-2031)
8.2 Asia-Pacific Antibody Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Development Services Market Size (2020-2031)
9.2 Latin America Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Development Services Market Size by Country (2020-2025)
9.4 Latin America Antibody Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Development Services Market Size (2020-2031)
10.2 Middle East & Africa Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Antibody Development Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Antibody Development Services Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Details
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Antibody Development Services Introduction
11.2.4 R&D Systems Revenue in Antibody Development Services Business (2020-2025)
11.2.5 R&D Systems Recent Development
11.3 Leinco Technologies
11.3.1 Leinco Technologies Company Details
11.3.2 Leinco Technologies Business Overview
11.3.3 Leinco Technologies Antibody Development Services Introduction
11.3.4 Leinco Technologies Revenue in Antibody Development Services Business (2020-2025)
11.3.5 Leinco Technologies Recent Development
11.4 Rockland Immunochemicals, Inc. (Rockland)
11.4.1 Rockland Immunochemicals, Inc. (Rockland) Company Details
11.4.2 Rockland Immunochemicals, Inc. (Rockland) Business Overview
11.4.3 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Introduction
11.4.4 Rockland Immunochemicals, Inc. (Rockland) Revenue in Antibody Development Services Business (2020-2025)
11.4.5 Rockland Immunochemicals, Inc. (Rockland) Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Antibody Development Services Introduction
11.5.4 Bio-Rad Revenue in Antibody Development Services Business (2020-2025)
11.5.5 Bio-Rad Recent Development
11.6 BioGenes
11.6.1 BioGenes Company Details
11.6.2 BioGenes Business Overview
11.6.3 BioGenes Antibody Development Services Introduction
11.6.4 BioGenes Revenue in Antibody Development Services Business (2020-2025)
11.6.5 BioGenes Recent Development
11.7 ProteoGenix
11.7.1 ProteoGenix Company Details
11.7.2 ProteoGenix Business Overview
11.7.3 ProteoGenix Antibody Development Services Introduction
11.7.4 ProteoGenix Revenue in Antibody Development Services Business (2020-2025)
11.7.5 ProteoGenix Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Antibody Development Services Introduction
11.8.4 Labcorp Revenue in Antibody Development Services Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 Inotiv, Inc.
11.9.1 Inotiv, Inc. Company Details
11.9.2 Inotiv, Inc. Business Overview
11.9.3 Inotiv, Inc. Antibody Development Services Introduction
11.9.4 Inotiv, Inc. Revenue in Antibody Development Services Business (2020-2025)
11.9.5 Inotiv, Inc. Recent Development
11.10 ProMab Biotechnologies
11.10.1 ProMab Biotechnologies Company Details
11.10.2 ProMab Biotechnologies Business Overview
11.10.3 ProMab Biotechnologies Antibody Development Services Introduction
11.10.4 ProMab Biotechnologies Revenue in Antibody Development Services Business (2020-2025)
11.10.5 ProMab Biotechnologies Recent Development
11.11 Kemp Proteins
11.11.1 Kemp Proteins Company Details
11.11.2 Kemp Proteins Business Overview
11.11.3 Kemp Proteins Antibody Development Services Introduction
11.11.4 Kemp Proteins Revenue in Antibody Development Services Business (2020-2025)
11.11.5 Kemp Proteins Recent Development
11.12 Synaptic Systems
11.12.1 Synaptic Systems Company Details
11.12.2 Synaptic Systems Business Overview
11.12.3 Synaptic Systems Antibody Development Services Introduction
11.12.4 Synaptic Systems Revenue in Antibody Development Services Business (2020-2025)
11.12.5 Synaptic Systems Recent Development
11.13 ARVYS Proteins, Inc.
11.13.1 ARVYS Proteins, Inc. Company Details
11.13.2 ARVYS Proteins, Inc. Business Overview
11.13.3 ARVYS Proteins, Inc. Antibody Development Services Introduction
11.13.4 ARVYS Proteins, Inc. Revenue in Antibody Development Services Business (2020-2025)
11.13.5 ARVYS Proteins, Inc. Recent Development
11.14 BBI Solutions
11.14.1 BBI Solutions Company Details
11.14.2 BBI Solutions Business Overview
11.14.3 BBI Solutions Antibody Development Services Introduction
11.14.4 BBI Solutions Revenue in Antibody Development Services Business (2020-2025)
11.14.5 BBI Solutions Recent Development
11.15 Innovagen AB
11.15.1 Innovagen AB Company Details
11.15.2 Innovagen AB Business Overview
11.15.3 Innovagen AB Antibody Development Services Introduction
11.15.4 Innovagen AB Revenue in Antibody Development Services Business (2020-2025)
11.15.5 Innovagen AB Recent Development
11.16 BIOTEM
11.16.1 BIOTEM Company Details
11.16.2 BIOTEM Business Overview
11.16.3 BIOTEM Antibody Development Services Introduction
11.16.4 BIOTEM Revenue in Antibody Development Services Business (2020-2025)
11.16.5 BIOTEM Recent Development
11.17 Medimab
11.17.1 Medimab Company Details
11.17.2 Medimab Business Overview
11.17.3 Medimab Antibody Development Services Introduction
11.17.4 Medimab Revenue in Antibody Development Services Business (2020-2025)
11.17.5 Medimab Recent Development
11.18 OriGene
11.18.1 OriGene Company Details
11.18.2 OriGene Business Overview
11.18.3 OriGene Antibody Development Services Introduction
11.18.4 OriGene Revenue in Antibody Development Services Business (2020-2025)
11.18.5 OriGene Recent Development
11.19 Abeomics Inc.
11.19.1 Abeomics Inc. Company Details
11.19.2 Abeomics Inc. Business Overview
11.19.3 Abeomics Inc. Antibody Development Services Introduction
11.19.4 Abeomics Inc. Revenue in Antibody Development Services Business (2020-2025)
11.19.5 Abeomics Inc. Recent Development
11.20 RayBiotech
11.20.1 RayBiotech Company Details
11.20.2 RayBiotech Business Overview
11.20.3 RayBiotech Antibody Development Services Introduction
11.20.4 RayBiotech Revenue in Antibody Development Services Business (2020-2025)
11.20.5 RayBiotech Recent Development
11.21 Genscript Biotech Corporation
11.21.1 Genscript Biotech Corporation Company Details
11.21.2 Genscript Biotech Corporation Business Overview
11.21.3 Genscript Biotech Corporation Antibody Development Services Introduction
11.21.4 Genscript Biotech Corporation Revenue in Antibody Development Services Business (2020-2025)
11.21.5 Genscript Biotech Corporation Recent Development
11.22 Sino Biological
11.22.1 Sino Biological Company Details
11.22.2 Sino Biological Business Overview
11.22.3 Sino Biological Antibody Development Services Introduction
11.22.4 Sino Biological Revenue in Antibody Development Services Business (2020-2025)
11.22.5 Sino Biological Recent Development
11.23 Abzena Ltd
11.23.1 Abzena Ltd Company Details
11.23.2 Abzena Ltd Business Overview
11.23.3 Abzena Ltd Antibody Development Services Introduction
11.23.4 Abzena Ltd Revenue in Antibody Development Services Business (2020-2025)
11.23.5 Abzena Ltd Recent Development
11.24 Creative Biolabs
11.24.1 Creative Biolabs Company Details
11.24.2 Creative Biolabs Business Overview
11.24.3 Creative Biolabs Antibody Development Services Introduction
11.24.4 Creative Biolabs Revenue in Antibody Development Services Business (2020-2025)
11.24.5 Creative Biolabs Recent Development
11.25 Abcam
11.25.1 Abcam Company Details
11.25.2 Abcam Business Overview
11.25.3 Abcam Antibody Development Services Introduction
11.25.4 Abcam Revenue in Antibody Development Services Business (2020-2025)
11.25.5 Abcam Recent Development
11.26 Antibodies Incorporated
11.26.1 Antibodies Incorporated Company Details
11.26.2 Antibodies Incorporated Business Overview
11.26.3 Antibodies Incorporated Antibody Development Services Introduction
11.26.4 Antibodies Incorporated Revenue in Antibody Development Services Business (2020-2025)
11.26.5 Antibodies Incorporated Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibody Development
Table 3. Key Players of Polyclonal Antibody Development
Table 4. Global Antibody Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antibody Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antibody Development Services Market Share by Region (2020-2025)
Table 8. Global Antibody Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antibody Development Services Market Share by Region (2026-2031)
Table 10. Antibody Development Services Market Trends
Table 11. Antibody Development Services Market Drivers
Table 12. Antibody Development Services Market Challenges
Table 13. Antibody Development Services Market Restraints
Table 14. Global Antibody Development Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antibody Development Services Market Share by Players (2020-2025)
Table 16. Global Top Antibody Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Development Services as of 2024)
Table 17. Ranking of Global Top Antibody Development Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antibody Development Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antibody Development Services, Headquarters and Area Served
Table 20. Global Key Players of Antibody Development Services, Product and Application
Table 21. Global Key Players of Antibody Development Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody Development Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antibody Development Services Revenue Market Share by Type (2020-2025)
Table 25. Global Antibody Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antibody Development Services Revenue Market Share by Type (2026-2031)
Table 27. Global Antibody Development Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antibody Development Services Revenue Market Share by Application (2020-2025)
Table 29. Global Antibody Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antibody Development Services Revenue Market Share by Application (2026-2031)
Table 31. North America Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antibody Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antibody Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antibody Development Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Details
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific Antibody Development Services Product
Table 49. Thermo Fisher Scientific Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. R&D Systems Company Details
Table 52. R&D Systems Business Overview
Table 53. R&D Systems Antibody Development Services Product
Table 54. R&D Systems Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 55. R&D Systems Recent Development
Table 56. Leinco Technologies Company Details
Table 57. Leinco Technologies Business Overview
Table 58. Leinco Technologies Antibody Development Services Product
Table 59. Leinco Technologies Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 60. Leinco Technologies Recent Development
Table 61. Rockland Immunochemicals, Inc. (Rockland) Company Details
Table 62. Rockland Immunochemicals, Inc. (Rockland) Business Overview
Table 63. Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Product
Table 64. Rockland Immunochemicals, Inc. (Rockland) Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 65. Rockland Immunochemicals, Inc. (Rockland) Recent Development
Table 66. Bio-Rad Company Details
Table 67. Bio-Rad Business Overview
Table 68. Bio-Rad Antibody Development Services Product
Table 69. Bio-Rad Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 70. Bio-Rad Recent Development
Table 71. BioGenes Company Details
Table 72. BioGenes Business Overview
Table 73. BioGenes Antibody Development Services Product
Table 74. BioGenes Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 75. BioGenes Recent Development
Table 76. ProteoGenix Company Details
Table 77. ProteoGenix Business Overview
Table 78. ProteoGenix Antibody Development Services Product
Table 79. ProteoGenix Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 80. ProteoGenix Recent Development
Table 81. Labcorp Company Details
Table 82. Labcorp Business Overview
Table 83. Labcorp Antibody Development Services Product
Table 84. Labcorp Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 85. Labcorp Recent Development
Table 86. Inotiv, Inc. Company Details
Table 87. Inotiv, Inc. Business Overview
Table 88. Inotiv, Inc. Antibody Development Services Product
Table 89. Inotiv, Inc. Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 90. Inotiv, Inc. Recent Development
Table 91. ProMab Biotechnologies Company Details
Table 92. ProMab Biotechnologies Business Overview
Table 93. ProMab Biotechnologies Antibody Development Services Product
Table 94. ProMab Biotechnologies Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 95. ProMab Biotechnologies Recent Development
Table 96. Kemp Proteins Company Details
Table 97. Kemp Proteins Business Overview
Table 98. Kemp Proteins Antibody Development Services Product
Table 99. Kemp Proteins Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 100. Kemp Proteins Recent Development
Table 101. Synaptic Systems Company Details
Table 102. Synaptic Systems Business Overview
Table 103. Synaptic Systems Antibody Development Services Product
Table 104. Synaptic Systems Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 105. Synaptic Systems Recent Development
Table 106. ARVYS Proteins, Inc. Company Details
Table 107. ARVYS Proteins, Inc. Business Overview
Table 108. ARVYS Proteins, Inc. Antibody Development Services Product
Table 109. ARVYS Proteins, Inc. Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 110. ARVYS Proteins, Inc. Recent Development
Table 111. BBI Solutions Company Details
Table 112. BBI Solutions Business Overview
Table 113. BBI Solutions Antibody Development Services Product
Table 114. BBI Solutions Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 115. BBI Solutions Recent Development
Table 116. Innovagen AB Company Details
Table 117. Innovagen AB Business Overview
Table 118. Innovagen AB Antibody Development Services Product
Table 119. Innovagen AB Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 120. Innovagen AB Recent Development
Table 121. BIOTEM Company Details
Table 122. BIOTEM Business Overview
Table 123. BIOTEM Antibody Development Services Product
Table 124. BIOTEM Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 125. BIOTEM Recent Development
Table 126. Medimab Company Details
Table 127. Medimab Business Overview
Table 128. Medimab Antibody Development Services Product
Table 129. Medimab Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 130. Medimab Recent Development
Table 131. OriGene Company Details
Table 132. OriGene Business Overview
Table 133. OriGene Antibody Development Services Product
Table 134. OriGene Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 135. OriGene Recent Development
Table 136. Abeomics Inc. Company Details
Table 137. Abeomics Inc. Business Overview
Table 138. Abeomics Inc. Antibody Development Services Product
Table 139. Abeomics Inc. Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 140. Abeomics Inc. Recent Development
Table 141. RayBiotech Company Details
Table 142. RayBiotech Business Overview
Table 143. RayBiotech Antibody Development Services Product
Table 144. RayBiotech Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 145. RayBiotech Recent Development
Table 146. Genscript Biotech Corporation Company Details
Table 147. Genscript Biotech Corporation Business Overview
Table 148. Genscript Biotech Corporation Antibody Development Services Product
Table 149. Genscript Biotech Corporation Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 150. Genscript Biotech Corporation Recent Development
Table 151. Sino Biological Company Details
Table 152. Sino Biological Business Overview
Table 153. Sino Biological Antibody Development Services Product
Table 154. Sino Biological Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 155. Sino Biological Recent Development
Table 156. Abzena Ltd Company Details
Table 157. Abzena Ltd Business Overview
Table 158. Abzena Ltd Antibody Development Services Product
Table 159. Abzena Ltd Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 160. Abzena Ltd Recent Development
Table 161. Creative Biolabs Company Details
Table 162. Creative Biolabs Business Overview
Table 163. Creative Biolabs Antibody Development Services Product
Table 164. Creative Biolabs Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 165. Creative Biolabs Recent Development
Table 166. Abcam Company Details
Table 167. Abcam Business Overview
Table 168. Abcam Antibody Development Services Product
Table 169. Abcam Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 170. Abcam Recent Development
Table 171. Antibodies Incorporated Company Details
Table 172. Antibodies Incorporated Business Overview
Table 173. Antibodies Incorporated Antibody Development Services Product
Table 174. Antibodies Incorporated Revenue in Antibody Development Services Business (2020-2025) & (US$ Million)
Table 175. Antibodies Incorporated Recent Development
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
Table 179. Authors List of This Report


List of Figures
Figure 1. Antibody Development Services Picture
Figure 2. Global Antibody Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Development Services Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibody Development Features
Figure 5. Polyclonal Antibody Development Features
Figure 6. Global Antibody Development Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antibody Development Services Market Share by Application: 2024 VS 2031
Figure 8. Medical Industry Case Studies
Figure 9. Biological Industry Case Studies
Figure 10. Others Case Studies
Figure 11. Antibody Development Services Report Years Considered
Figure 12. Global Antibody Development Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Antibody Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antibody Development Services Market Share by Region: 2024 VS 2031
Figure 15. Global Antibody Development Services Market Share by Players in 2024
Figure 16. Global Top Antibody Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Development Services as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Antibody Development Services Revenue in 2024
Figure 18. North America Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Antibody Development Services Market Share by Country (2020-2031)
Figure 20. United States Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antibody Development Services Market Share by Country (2020-2031)
Figure 24. Germany Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antibody Development Services Market Share by Region (2020-2031)
Figure 32. China Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antibody Development Services Market Share by Country (2020-2031)
Figure 40. Mexico Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antibody Development Services Market Share by Country (2020-2031)
Figure 44. Turkey Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 48. R&D Systems Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 49. Leinco Technologies Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 50. Rockland Immunochemicals, Inc. (Rockland) Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 51. Bio-Rad Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 52. BioGenes Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 53. ProteoGenix Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 54. Labcorp Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 55. Inotiv, Inc. Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 56. ProMab Biotechnologies Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 57. Kemp Proteins Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 58. Synaptic Systems Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 59. ARVYS Proteins, Inc. Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 60. BBI Solutions Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 61. Innovagen AB Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 62. BIOTEM Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 63. Medimab Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 64. OriGene Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 65. Abeomics Inc. Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 66. RayBiotech Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 67. Genscript Biotech Corporation Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 68. Sino Biological Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 69. Abzena Ltd Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 70. Creative Biolabs Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 71. Abcam Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 72. Antibodies Incorporated Revenue Growth Rate in Antibody Development Services Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies